Also published in Aktien:
Aplicor Names Donald Zebe as CEO; Don McKinney Continues as Chairman of the Board
x hide permanently

MEDITE Cancer Diagnostics Appoints Eric M. Goehausen to Board of Directors

Aktien

MEDITE Cancer Diagnostics, Inc., a medical technology company specializing in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases, today announced that Mr. Eric M. Goehausen has been elected to MEDITE's Board of Directors...

Mentions: technology Board of Directors